157 related articles for article (PubMed ID: 27827304)
21. Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.
Pathria G; Garg B; Borgdorff V; Garg K; Wagner C; Superti-Furga G; Wagner SN
Cell Death Dis; 2016 Mar; 7(3):e2135. PubMed ID: 26962685
[TBL] [Abstract][Full Text] [Related]
22. Beyond MITF: Multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanoma.
Seberg HE; Van Otterloo E; Cornell RA
Pigment Cell Melanoma Res; 2017 Sep; 30(5):454-466. PubMed ID: 28649789
[TBL] [Abstract][Full Text] [Related]
23. A genomic screen identifies TYRO3 as a MITF regulator in melanoma.
Zhu S; Wurdak H; Wang Y; Galkin A; Tao H; Li J; Lyssiotis CA; Yan F; Tu BP; Miraglia L; Walker J; Sun F; Orth A; Schultz PG; Wu X
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17025-30. PubMed ID: 19805117
[TBL] [Abstract][Full Text] [Related]
24. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
Vachtenheim J; Novotná H
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
[TBL] [Abstract][Full Text] [Related]
25. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.
Laurette P; Strub T; Koludrovic D; Keime C; Le Gras S; Seberg H; Van Otterloo E; Imrichova H; Siddaway R; Aerts S; Cornell RA; Mengus G; Davidson I
Elife; 2015 Mar; 4():. PubMed ID: 25803486
[TBL] [Abstract][Full Text] [Related]
26. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
[TBL] [Abstract][Full Text] [Related]
27. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D
Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137
[TBL] [Abstract][Full Text] [Related]
28. Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma.
Gelmi MC; Verdijk RM; Houtzagers LE; van der Velden PA; Kroes WGM; Luyten GPM; Vu THK; Jager MJ
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240204
[TBL] [Abstract][Full Text] [Related]
29. 8-Methoxybutin inhibits α-MSH induced melanogenesis and proliferation of skin melanoma by suppression of the transactivation activity of microphthalmia-associated transcription factor.
Oh E; Kim HJ; Lee D; Kang JH; Kim HG; Han SH; Baek NI; Kim KT
Biomed Pharmacother; 2022 Aug; 152():113272. PubMed ID: 35716437
[TBL] [Abstract][Full Text] [Related]
30. Development of an HTS-compatible assay for the discovery of ASK1 signalosome inhibitors using alphascreen technology.
Sturchler E; Chen W; Spicer T; Hodder P; McDonald P; Duckett D
Assay Drug Dev Technol; 2014 May; 12(4):229-37. PubMed ID: 24831789
[TBL] [Abstract][Full Text] [Related]
31. PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.
Grabacka M; Placha W; Urbanska K; Laidler P; Płonka PM; Reiss K
Pigment Cell Melanoma Res; 2008 Jun; 21(3):388-96. PubMed ID: 18444964
[TBL] [Abstract][Full Text] [Related]
32. The roles of microphthalmia-associated transcription factor and pigmentation in melanoma.
Hsiao JJ; Fisher DE
Arch Biochem Biophys; 2014 Dec; 563():28-34. PubMed ID: 25111671
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.
Cheli Y; Giuliano S; Fenouille N; Allegra M; Hofman V; Hofman P; Bahadoran P; Lacour JP; Tartare-Deckert S; Bertolotto C; Ballotti R
Oncogene; 2012 May; 31(19):2461-70. PubMed ID: 21996743
[TBL] [Abstract][Full Text] [Related]
34. MITF-the first 25 years.
Goding CR; Arnheiter H
Genes Dev; 2019 Aug; 33(15-16):983-1007. PubMed ID: 31123060
[TBL] [Abstract][Full Text] [Related]
35. The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
Lu S; Slominski A; Yang SE; Sheehan C; Ross J; Carlson JA
J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):26-40. PubMed ID: 20482673
[TBL] [Abstract][Full Text] [Related]
36. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.
McGill GG; Horstmann M; Widlund HR; Du J; Motyckova G; Nishimura EK; Lin YL; Ramaswamy S; Avery W; Ding HF; Jordan SA; Jackson IJ; Korsmeyer SJ; Golub TR; Fisher DE
Cell; 2002 Jun; 109(6):707-18. PubMed ID: 12086670
[TBL] [Abstract][Full Text] [Related]
37. Regulation of MITF stability by the USP13 deubiquitinase.
Zhao X; Fiske B; Kawakami A; Li J; Fisher DE
Nat Commun; 2011 Aug; 2():414. PubMed ID: 21811243
[TBL] [Abstract][Full Text] [Related]
38. Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF.
Takeda K; Yokoyama S; Aburatani H; Masuda T; Han F; Yoshizawa M; Yamaki N; Yamamoto H; Eguchi N; Urade Y; Shibahara S
Biochem Biophys Res Commun; 2006 Jan; 339(4):1098-106. PubMed ID: 16337607
[TBL] [Abstract][Full Text] [Related]
39. MITF, the Janus transcription factor of melanoma.
Koludrovic D; Davidson I
Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
[TBL] [Abstract][Full Text] [Related]
40. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
Wellbrock C; Marais R
J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
